Minimum important difference for validated instruments in women with urge incontinence. - Wikidata - awgldk - TriplyDB

Minimum important difference for validated instruments in women with urge incontinence.

Minimum important difference for validated instruments in women with urge incontinence.

http://www.wikidata.org/entity/Q30353491

about

The effect of mirabegron on patient-related outcomes in patients with overactive bladder: the results of post hoc correlation and responder analyses using pooled data from three randomized Phase III trials The minimum important difference for the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form in women with stress urinary incontinence.Life Space Assessment in Older Women Undergoing Non-Surgical Treatment for Urinary Incontinence Impact of urinary incontinence on health-related quality of life, daily activities, and healthcare resource utilization in patients with neurogenic detrusor overactivity.Outcomes of midurethral sling procedures in women with mixed urinary incontinence.Impact of overactive bladder on quality of life and resource use: results from Korean Burden of Incontinence Study (KOBIS).Anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence.Methods for a multicenter randomized trial for mixed urinary incontinence: rationale and patient-centeredness of the ESTEEM trial.Patient-reported outcomes in patients with overactive bladder treated with mirabegron and tolterodine in a prospective, double-blind, randomized, two-period crossover, multicenter study (PREFER).

P2860

Q30894093-180A247C-29E9-49EF-A33C-42D9DAF9241E Q33655386-6CEC760F-A15F-4FFD-98DF-5EA99810678C Q34707493-BEA1B21A-021B-41DC-9CBB-723BC031D4CF Q35141099-23249E2C-3670-4317-B287-64EFBCF48596 Q35537111-F3D64ABD-BA96-4B23-9DD0-5B27725BCAEB Q35780487-29996D8C-417C-4464-92E1-8426D633437B Q36528534-3D912183-247A-4FD9-9894-6A3A68CBD8CD Q41644524-487B83D7-29CB-4AFD-BB53-57159B3B506E Q55359372-29FB65D3-A65C-45F4-9626-57F5EFA3D291

P2860

Minimum important difference for validated instruments in women with urge incontinence.

http://www.wikidata.org/entity/Q30353491

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

name

Minimum important difference for validated instruments in women with urge incontinence.

@ast

Minimum important difference for validated instruments in women with urge incontinence.

@en

type

label

Minimum important difference for validated instruments in women with urge incontinence.

@ast

Minimum important difference for validated instruments in women with urge incontinence.

@en

prefLabel

Minimum important difference for validated instruments in women with urge incontinence.

@ast

Minimum important difference for validated instruments in women with urge incontinence.

@en

P1433

Q30353491-3B4D2C0E-C069-4441-8C77-A0CE213FC22A

P1476

Q30353491-DB6503D5-D30F-4362-A3A7-E54F4023803D

P2093

Q30353491-3E3A2ABC-0956-4371-A537-95B84D0FE437

Q30353491-46D7888D-E1F4-474F-9E7D-3DB59DD12DBB

Q30353491-50F0F308-6F79-460A-9B3D-64B23BCEC781

Q30353491-56A81A63-8BDA-408E-A3B9-4D1D5E29B128

Q30353491-580786E2-F4CB-45D0-B432-E6D82089066B

Q30353491-72CFD7BC-7C41-40A0-A1D4-9686A10B437C

Q30353491-99C77F14-2141-46BE-BCC1-B1F03C74945E

Q30353491-A1163E8B-1964-4520-9DC4-127489DEB885

Q30353491-ACEEBA98-83F6-4B4D-88A9-7C11305649CB

Q30353491-CC5CAEA6-01A2-45C0-8E2E-4B4E5EC4459D

P2860

Q30353491-28FA7125-87C0-4791-A835-9E062B1C6FBB

Q30353491-3C7C27AF-BB7D-4FA3-8F7E-5B9FE0063788

Q30353491-56A3A74A-0EB2-4B72-BF2A-E782034B8130

Q30353491-62E7D261-A167-4503-BE35-3B7BD8F60777

Q30353491-69C25EDB-9260-4B4F-8A63-03AC89D34E5A

Q30353491-743E6F48-91A3-4BD6-9866-BCA2E5C66D65

Q30353491-75D01C5D-C78B-46B5-B100-3A7A5779CD53

Q30353491-7D520CB1-608E-4D99-9B54-82881AA3AC64

Q30353491-82A30FEF-537F-48D1-AF0E-CABE6A4832C9

Q30353491-8FDDFAE8-4B95-483A-98BC-C962D5DE2EE9

P304

Q30353491-E6A4E5C9-D424-4B6B-A62F-923EC59890D4

P31

Q30353491-4016449D-E508-48B2-B0F4-BF3596BE2CBB

P356

Q30353491-00D09FA3-D5D2-48C8-B5AC-4DD4E8FC5072

P433

Q30353491-29914BD7-DF83-4BCC-A48E-BC92EB77804D

P478

Q30353491-C60F6FFB-A17E-4545-BCDD-F02B80A27802

P577

Q30353491-FE24183A-919C-4C76-81AA-EA9C0C0B5A78

P698

Q30353491-50E68995-668E-4BCE-BEC1-1B4C8B7E111D

P932

Q30353491-5F47129F-3AC8-4251-BA44-BAA88A3484F8

P356

P1433

Neurourology and Urodynamics

P1476

Minimum important difference for validated instruments in women with urge incontinence.

@en

P2093

Alayne Markland

http://www.w3.org/2001/XMLSchema#string

Ann Stoddard

http://www.w3.org/2001/XMLSchema#string

David Rahn

http://www.w3.org/2001/XMLSchema#string

Emily Lukacz

http://www.w3.org/2001/XMLSchema#string

Ingrid Nygaard

http://www.w3.org/2001/XMLSchema#string

Keisha Y Dyer

http://www.w3.org/2001/XMLSchema#string

Linda Brubaker

http://www.w3.org/2001/XMLSchema#string

Toby C Chai

http://www.w3.org/2001/XMLSchema#string

Urinary Incontinence Treatment Network (UITN)

http://www.w3.org/2001/XMLSchema#string

Yan Xu

http://www.w3.org/2001/XMLSchema#string

P2860

Behavioral therapy to enable women with urge incontinence to discontinue drug treatment: a randomized trial.

Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life.

Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes.

Correlations among improvements in urgency urinary incontinence, health-related quality of life, and perception of bladder-related problems in incontinent subjects with overactive bladder treated with tolterodine or placebo.

The minimum important differences for the urinary scales of the Pelvic Floor Distress Inventory and Pelvic Floor Impact Questionnaire.

Using the standard error of measurement to identify important changes on the Asthma Quality of Life Questionnaire.

Costs of urinary incontinence and overactive bladder in the United States: a comparative study.

The responsiveness of the Overactive Bladder Questionnaire (OAB-q).

Determining the importance of change in the overactive bladder questionnaire.

The impact on health-related quality of life of stress, urge and mixed urinary incontinence.

P304

1319-1324

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/NAU.21028

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21563210

http://www.w3.org/2001/XMLSchema#string

P932

5373473

http://www.w3.org/2001/XMLSchema#string